TCL Archive In Brief: Cancer Act, Accelerated Progress, ACS President Says; Scanners Scapegoats, EMI Chief Claimes April 7, 1978
TCL Archive FDA Blocks Nine More INDs; Cooperative Group Chairmen, DeVita Blast “Lack of Expertise” January 7, 1977
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive Multiple Studies Show Benefit of CTL019, A Personalized Therapy, in CLL and ALL December 27, 2013
TCL Archive Cooperative Groups Should Be Trimmed, Brought Under Control Of DCT, Surgical Panel Suggests May 31, 1974
